Executive Summary
On January 7, 2026, the US SEC filings revealed a high volume of routine disclosures dominated by executive changes (over 50 instances, Item 5.02), earnings releases (numerous Item 2.02), and material agreements/acquisitions (multiple Item 1.01/2.01), with overwhelmingly neutral sentiment but elevated activity in biotech/pharma and small-cap M&A. Cumulative patterns indicate widespread leadership turnover potentially signaling governance instability, alongside clusters of delistings and auditor changes raising red flags for liquidity and accounting risks in micro-caps and energy firms. Market implications suggest a quiet trading day with limited broad volatility, but alpha opportunities in reviewing M&A financial exhibits and monitoring delisting-impacted names for short opportunities.
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from January 05, 2026.
Investment Signals(5)
- β²
Multiple completed acquisitions (e.g., Permian Resources, VisionWave Holdings, National Bank Holdings) with attached financials signal potential synergies [BULLISH] - Permian Resources Corp, VisionWave Holdings
- β²
Clusters of earnings disclosures without detailed metrics (e.g., AbbVie, UniFirst, Constellation Brands) may preview earnings season beats if exhibits positive [BULLISH] - AbbVie Inc., UniFirst Corp
- β²
Frequent unregistered equity sales (Item 3.02 across 20+ filings) imply dilution pressure [BEARISH] - Various small-caps including Unknown Companies, D-Wave Quantum
- β²
Delistings and listing failures (Item 3.01 in Permian, Cidara, Inotiv, Biofrontera) erode liquidity [BEARISH] - Permian Resources, Biofrontera Inc.
- β²
Auditor changes (Item 4.01 in Timberland Bancorp, Riverview Bancorp, Cheetah Net) flag accounting concerns [BEARISH] - Timberland Bancorp, Cheetah Net Supply Chain
Risk Flags(4)
- βΌ
Widespread executive turnover (50+ Item 5.02 filings) across biotech and small-caps suggests systemic leadership instability and potential operational disruptions
- βΌ
Multiple delistings (Permian Resources, Cidara Therapeutics, Inotiv, Biofrontera, Propanc) cluster in energy/biotech, risking sharp liquidity drops and OTC transitions
- βΌ
Auditor changes in financials (Timberland Bancorp, Riverview, Cheetah Net, SharonAI) without reasons disclosed signal potential material weaknesses or disagreements
- βΌ
Heavy unregistered equity issuances (Item 3.02 in 25+ filings) amplify dilution risks amid M&A activity
Opportunities(4)
- β
Strategic M&A completions (e.g., Permian Resources high-materiality merger with exhibits) offer review of pro forma financials for undervalued assets
- β
Earnings clusters (Blue Owl entities, AbbVie, UniFirst) provide entry points if full exhibits beat consensus upon deeper analysis
- β
Post-delisting shorts on liquidity-constrained names (Biofrontera, Propanc) for tactical plays
- β
Biotech Reg FD disclosures (Rapport Therapeutics, Adicet Bio) may reveal pipeline catalysts hidden in exhibits
Sector Themes(3)
- β
Biotech/pharma leadership churn and 'Other Events' (30+ filings: 4D Molecular, Oramed, Moleculin, Processa) points to R&D pipeline volatility and funding pressures
- β
Small-cap/energy M&A frenzy with delistings (Permian Resources, ASP Isotopes) indicates consolidation amid liquidity strains
- β
Financial services routine earnings/Reg FD (Blue Owl, CION, Universal Insurance) reflects stable sector reporting ahead of broader season
Watch List(4)
- π
Permian Resources Corp merger/delisting - High materiality (9/10) with control changes; monitor OTC transition and synergies
- π
Biofrontera Inc./Propanc Biopharma delistings - Critical risk (10/10); track shareholder reactions and potential buyouts
- π
Auditor changers (Timberland Bancorp, Riverview Bancorp) - Medium-high materiality; watch for 10-K restatements or SEC inquiries
- π
Executive turnover clusters (e.g., Enliven Therapeutics, SAB Biotherapeutics) - Assess governance ripple effects in biotech portfolios
Filing Analyses(237)
07-01-2026
4D Molecular Therapeutics, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005470, Size: 164 KB). The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on officers, reasons, financial metrics, or changes are provided.
07-01-2026
Tredegar Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005481, Size: 133 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, appointment or resignation status, reasons, individuals involved, or quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Blue Owl Capital Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005489, Size: 145 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing disclosing financial results with no specific revenue, earnings, transaction values, or other quantitative metrics provided in the summary. Sector is not specified.
07-01-2026
Blue Owl Technology Finance Corp. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005488, Size: 147 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a US market event. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
07-01-2026
Oramed Pharmaceuticals Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-001983, Size: 198 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are provided in the filing summary. Sector not specified.
07-01-2026
WHITE MOUNTAINS INSURANCE GROUP LTD filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001102, Size: 138 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
THUMZUP MEDIA Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000727, Size: 18 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or financial statements are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Digi Power X Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-001966, Size: 238 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. Sector is not specified.
07-01-2026
Permian Resources Corp filed an 8-K on January 7, 2026 (AccNo: 0001193125-26-006312, Size: 1 MB), announcing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation/bylaws or fiscal year change (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This indicates a completed merger/acquisition event with significant corporate changes. No specific parties, deal structure, valuation, or financial metrics are disclosed.
07-01-2026
LM Funding America, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005468, size 224 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure.
07-01-2026
California BanCorp (CA) filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000728, Size: 360 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Zeo ScientifiX, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001829126-26-000073, size 300 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Versant Media Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000950103-26-000204, Size: 429 KB), reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. Sector not specified. No specific details on the nature of amendments, changes, or exhibits provided in the filing summary.
07-01-2026
UniFirst Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005469, Size: 1 MB), reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US market. No specific revenue, earnings, transaction values, or other financial metrics are mentioned.
07-01-2026
MOBIX LABS, INC filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000731, Size: 704 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. Sector is not specified.
07-01-2026
Moleculin Biotech, Inc. filed a Form 8-K on January 07, 2026, under Item 8.01 Other Events. Accession number: 0001437749-26-000695. File size: 164 KB. No specific details on the event, transaction, or financial impacts are disclosed.
07-01-2026
SAB Biotherapeutics, Inc. disclosed an officer change via Form 8-K filed on January 07, 2026 (AccNo: 0001193125-26-005487, Size: 268 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided in the summary.
07-01-2026
Processa Pharmaceuticals, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000733, size: 200 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
07-01-2026
Rapport Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005499, Size: 195 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
BTCS Inc. filed an 8-K on January 07, 2026 (AccNo: 0001493152-26-000734, Size: 268 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, transaction values, or other quantitative metrics are mentioned in the provided filing summary. Sector is not specified.
07-01-2026
VisionWave Holdings, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001731122-26-000018, Size: 438 KB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and provides financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or strategic rationale are disclosed.
07-01-2026
CION Investment Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001616, Size: 288 KB), disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary.
07-01-2026
Worthington Enterprises, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005501, Size: 189 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with no numerical data or strategic details provided.
07-01-2026
Signing Day Sports, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-001978, Size: 260 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure with limited public information available.
07-01-2026
Adicet Bio, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005486, Size: 225 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other content are disclosed in the provided filing summary. Sector not specified.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001999371-26-000372, Size: 615 KB) as a Material Event, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, obligation, transaction value, or parties are provided.
07-01-2026
Company filed a Form 8-K Item 3.02 on January 7, 2026, disclosing unregistered sales of equity securities. Filing Accession Number: 0002035428-26-000002, size 149 KB. No specific transaction details, values, shares, parties, or financial impacts provided.
07-01-2026
T-REX Acquisition Corp. filed an 8-K on January 7, 2026 (AccNo: 0001477932-26-000053, Size: 127 KB) under Item 5.02, disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No details on any merger, acquisition, or transaction structure are mentioned in the filing summary. Sector is not specified.
07-01-2026
Marqeta, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001522540-26-000004, Size: 184 KB), under Item 5.02 covering departures, elections, appointments, or compensatory arrangements of certain officers, and Item 9.01 for financial statements and exhibits. No specific details on the affected officer, position, reason, or terms are provided. Sector is not specified.
07-01-2026
UNIVERSAL INSURANCE HOLDINGS, INC. filed a Form 8-K on January 07, 2026 (AccNo: 0000891166-26-000002), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with a file size of 191 KB. No core event details, quantitative data, or financial metrics are explicitly stated in the provided filing summary.
07-01-2026
HEARTLAND EXPRESS INC filed a Form 8-K on January 7, 2026 (AccNo: 0000799233-26-000002, Size: 139 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the officer involved, nature of change (appointment or resignation), reasons, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Alaska Air Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000766421-26-000004, Size: 167 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, counterparties, transaction value, financial impacts, or other specifics are disclosed in the provided summary. This is a multi-item filing focused on a material event.
07-01-2026
Joby Aviation, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001819848-26-000040, Size: 982 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No details on the agreement, disclosures, transaction value, or financial impacts are explicitly stated. Sector not specified.
07-01-2026
AbbVie Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001551152-26-000002, Size: 256 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results announcement from the US SEC with no specific numerical financial metrics, transaction values, or detailed outcomes provided in the summary. Sector is not specified.
07-01-2026
Ameriserv Financial Inc./PA/ filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001622, Size: 293 KB), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item mandatory disclosure as a material event. No specific details on the agreement, sales, transaction values, or financial impacts are disclosed in the provided summary.
07-01-2026
Starwood Real Estate Income Trust, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-005534, Size: 153 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
07-01-2026
Cidara Therapeutics, Inc. filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-005517) disclosing termination of a material definitive agreement (Item 1.02), completion of acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of registrant (Item 5.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and financial statements/exhibits (Item 9.01). No specific parties, deal values, or financial metrics are disclosed. This indicates completion of a merger/acquisition event with resulting delisting and governance changes.
07-01-2026
Enliven Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005535, Size: 166 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, appointment/resignation status, or reasons are provided in the summary.
07-01-2026
Sera Prognostics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005531, Size: 201 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the attached exhibits are provided. This is a multi-item filing from the US market with sector not specified.
07-01-2026
ASP Isotopes Inc. filed an 8-K on 2026-01-07 (AccNo: 0001477932-26-000055, Size: 185 KB) disclosing completion of an acquisition or disposition of assets (Item 2.01), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or quantitative metrics are provided. Sector not specified.
07-01-2026
LENZ Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001815776-26-000003, Size: 179 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This is a multi-item filing focused on financial results announcement.
07-01-2026
The company filed an 8-K under Item 7.01 for Regulation FD Disclosure on January 07, 2026 (AccNo: 0001193125-26-005671, size: 147 KB). This is a general filing with event type 'General Filing' from source 'us_sec'. No specific details on events, transactions, financial metrics, or named entities are disclosed in the provided filing information.
07-01-2026
Atmus Filtration Technologies Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001921963-26-000004, Size: 68 MB), disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on transaction value, counterparties, financial impacts, or strategic rationale are provided in the available information. This is a multi-item mandatory filing for material events.
07-01-2026
The filing is a Form 8-K under Item 3.02 reporting unregistered sales of equity securities, dated January 07, 2026, with Accession Number 0001193125-26-005805 and file size 145 KB. No specific details on transaction value, share count, parties involved, or financial impacts are disclosed. This appears to be a mandatory disclosure for unregistered equity sales.
07-01-2026
FuboTV Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000807, Size: 449 KB), reporting entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing classified as a Material Event from US SEC source. No specific transaction details, dollar values, parties, or financial metrics are disclosed in the provided filing summary.
07-01-2026
Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005771, Size: 239 KB) reports Item 3.02 Unregistered Sales of Equity Securities and Item 8.01 Other Events. No specific details on transactions, values, entities, or impacts are disclosed in the provided filing summary. Sector not specified.
07-01-2026
Company filed Form 8-K on 2026-01-07 (AccNo: 0001193125-26-005768, Size: 203 KB) reporting Item 3.02 Unregistered Sales of Equity Securities and Item 8.01 Other Events. No specific details on transactions, values, parties, or events provided in the filing summary. Sector not specified.
07-01-2026
CHS INC filed a Form 8-K on January 7, 2026 (AccNo: 0000823277-26-000007, Size: 253 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific quantitative data, transaction details, or qualitative descriptions are provided in the filing summary. Sector is not specified.
07-01-2026
Twelve Seas Investment Co III/Cayman filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002161, Size: 260 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the events, transactions, financial statements, or exhibits are provided. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.
07-01-2026
D-Wave Quantum Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001907982-26-000012, Size: 2 MB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, financial metrics, transaction values, or other specifics are disclosed in the provided filing summary. This appears to be a voluntary disclosure related to Regulation FD.
07-01-2026
TRANSUITE.ORG INC. filed an 8-K on 2026-01-07 (AccNo: 0001640334-26-000042, Size: 231 KB) disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 2.01 Completion of Acquisition or Disposition of Assets, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, consideration, or strategic rationale are provided in the summary. All quantitative metrics such as transaction value, share counts, or financial impacts are NOT_DISCLOSED.
07-01-2026
ConnectM Technology Solutions, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001666, Size: 207 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on core events, transactions, financial impacts, or quantitative data are disclosed in the filing summary. This is a multi-item voluntary disclosure under Regulation FD.
07-01-2026
BiomX Inc. filed an 8-K on 2026-01-07 (AccNo: 0001213900-26-002160, Size: 253 KB) reporting the termination of a material definitive agreement under Item 1.02 and financial statements and exhibits under Item 9.01. No details on the agreement, counterparties, dollar values, or financial impacts are disclosed in the provided summary. Sector not specified.
07-01-2026
Bright Mountain Media, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000784), reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific transaction details, dollar values, terms, or related parties are disclosed in the provided filing summary. This appears to be a single-item mandatory disclosure for a potentially material event.
07-01-2026
Maison Solutions Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002071, Size: 191 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Timberland Bancorp Inc filed a Form 8-K on January 7, 2026 (AccNo: 0000939057-26-000003, Size: 194 KB) reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No details on the accountants involved, reasons for change, financial impacts, or quantitative data are provided.
07-01-2026
Columbus Acquisition Corp, a Cayman Islands entity, filed an 8-K on January 7, 2026 (AccNo: 0001213900-26-002088, size: 341 KB) announcing a merger/acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, consideration, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
SPECTRAL CAPITAL Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001096906-26-000033, Size: 179 KB) disclosing Entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. Sector not specified. No details on the agreement, transaction value, parties, or financial impacts provided.
07-01-2026
Unnamed company filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-006078, Size: 165 KB) disclosing Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Event classified as Officer Change dated January 07, 2026 from US SEC source. No specific details on officer name, position, appointment/resignation, reasons, compensation, or transaction terms provided.
07-01-2026
RIVERVIEW BANCORP INC filed a Form 8-K on January 07, 2026 (AccNo: 0000939057-26-000008, Size: 168 KB), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. This is a multi-item general filing from the US SEC with sector not specified. No transaction values, financial metrics, or additional details are disclosed.
07-01-2026
Aon plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005392, Size: 406 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001544, Size: 327 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is classified as a General Filing from us_sec with no sector specified. No details on the specific event, transaction, financial statements, or exhibits are provided.
07-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000717, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or exhibits are provided in the filing summary. Sector not specified.
07-01-2026
Clearway Energy, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001542, Size: 382 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
07-01-2026
CF Industries Holdings, Inc. disclosed an Officer Change event via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001551, Size: 190 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the available summary.
07-01-2026
National Bank Holdings Corp filed an 8-K on 2026-01-07 (AccNo: 0001104659-26-001549, Size: 264 KB) announcing completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure or election of directors/officers and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on parties, valuation, structure, or financial metrics are disclosed.
07-01-2026
Ionis Pharmaceuticals Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001140361-26-000435, Size: 191 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.
07-01-2026
Sow Good Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-004866, Size: 198 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), appointment or resignation, reasons, or any quantitative data are provided. Event dated January 07, 2026; sector not specified.
07-01-2026
Biohaven Ltd. filed a Form 8-K on January 7, 2026 (AccNo: 0001935979-26-000002, Size: 131 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
News Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001564708-26-000004, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or financial statements/exhibits are disclosed. Sector not specified.
07-01-2026
Diversified Energy Co filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000434, Size: 284 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the available information. Sector not specified.
07-01-2026
Archrock, Inc. filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001481, Size: 618 KB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing from US SEC source in an unspecified sector. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided information.
07-01-2026
Comstock Inc. filed a Form 8-K on January 07, 2026, reporting under Item 8.01 Other Events. The filing has accession number 0001437749-26-000673 and size of 160 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
07-01-2026
TECOGEN INC. filed a General Filing (Form 8-K) on January 07, 2026 (AccNo: 0001537435-26-000003, Size: 134 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on the disclosure content, events, transactions, or financial impacts are provided in the filing summary. Sector not specified.
07-01-2026
Cinemark Holdings, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-004875, Size: 260 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard financial results disclosure for a US equity market company in an unspecified sector. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
07-01-2026
American Clean Resources Group, Inc. disclosed an officer change event via Form 8-K filed on January 07, 2026 (AccNo: 0001213900-26-002127, Size: 194 KB), covering Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data provided. Sector not specified.
07-01-2026
Centessa Pharmaceuticals plc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-004896, Size: 361 KB), reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data such as transaction values, share counts, or percentages are disclosed in the provided information. Sector is not specified.
07-01-2026
Rezolute, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001556, Size: 6 MB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure of material nonpublic information with attached exhibits, but no specific core event, transaction details, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Cal-Maine Foods Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001562762-26-000002, size 323 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided filing summary. Sector not specified.
07-01-2026
GameStop Corp. filed a Form 8-K on January 07, 2026 (AccNo: 0001326380-26-000004, Size: 244 KB) as a General Filing from us_sec. The filing reports under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No sector is specified, and no further details on events, transactions, or financials are provided.
07-01-2026
COMPASS Pathways plc filed a Form 8-K on January 07, 2026 (AccNo: 0001816590-26-000004), reporting under Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), with exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing likely within the required 4-business-day window.
07-01-2026
MSC Industrial Direct Co Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001003078-26-000010, Size: 486 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a mandatory earnings-related disclosure.
07-01-2026
PSQ Holdings, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001573, size 396 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, named individuals, quantitative financial metrics, or governance impacts are NOT_DISCLOSED. Sector not specified.
07-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0000006845-26-000006, Size: 522 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or timing are explicitly stated. No quantitative financial metrics, transaction values, share counts, or percentages are mentioned.
07-01-2026
Compass, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001563190-26-000007, Size: 189 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific details on vote results, disclosures, or financial data provided in the summary. Sector not specified.
07-01-2026
CoStar Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001057352-26-000004, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, names, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005420), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but specific details of the core events, transactions, or exhibits are not disclosed in the provided filing summary. No quantitative data, named entities beyond the filer, or financial impacts are mentioned.
07-01-2026
Apogee Enterprises, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0000006845-26-000005, Size: 1 MB) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results disclosure. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.
07-01-2026
EyePoint Pharmaceuticals, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005418, Size: 340 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, revenue figures, earnings, or other quantitative details are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.
07-01-2026
Compass, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001563190-26-000005, size 1 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC, with sector not specified. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned in the provided filing summary.
07-01-2026
Genprex, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000694, Size: 8 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
BridgeBio Oncology Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005425), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item voluntary disclosure of unspecified other events.
07-01-2026
SharkNinja, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001957132-26-000003, Size: 155 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or compensation are disclosed in the provided summary. Sector is not specified.
07-01-2026
D-Wave Quantum Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001907982-26-000010, Size: 41 MB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, parties involved, financial impacts, or other quantitative data disclosed in the provided summary. Sector is not specified.
07-01-2026
Criteo S.A. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005427, Size: 208 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and material impacts are NOT_DISCLOSED.
07-01-2026
W. P. Carey Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001025378-26-000005, Size: 360 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no details provided on the content of the Regulation FD disclosure or specific financial statements/exhibits. All transaction values, financial metrics, and other quantitative data are NOT_DISCLOSED.
07-01-2026
The company filed an 8-K on 2026-01-07 (AccNo: 0001185185-26-000046, Size: 197 KB) under Item 4.02 announcing non-reliance on previously issued financial statements or a related audit report or completed interim review. This event is typed as Merger/Acquisition with no sector specified. No parties, deal structure, valuation, or financial metrics are disclosed.
07-01-2026
Anywhere Real Estate Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005430, size: 152 KB) under Item 8.01 Other Events. This is a general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector is not specified.
07-01-2026
InterDigital, Inc. filed a Form 8-K on January 7, 2026, under Item 8.01 Other Events. Accession Number: 0001628280-26-001101. File size: 139 KB. No specific event details, transaction values, or financial metrics disclosed in the provided filing summary.
07-01-2026
High Roller Technologies, Inc. filed an 8-K on January 07, 2026 (AccNo: 0001753926-26-000064, Size: 169 KB) under Item 2.01 announcing the completion of an acquisition or disposition of assets. No details on parties involved, deal structure, valuation, strategic rationale, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Company filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001747, Size: 27 KB) reporting Item 3.02 Unregistered Sales of Equity Securities and Item 7.01 Regulation FD Disclosure. No specific details on transaction value, shares, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item voluntary disclosure under Regulation FD.
07-01-2026
Extreme Networks Inc. (EXTREME NETWORKS INC) filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005441, Size: 160 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), individual names, appointment/resignation status, reasons, or quantitative data such as compensation amounts, share counts, or transaction values are provided in the filing summary. Sector is not specified.
07-01-2026
Rapport Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-005446, Size: 25 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No details on the core events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
07-01-2026
NRG Energy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001602, Size: 276 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary.
07-01-2026
Albertsons Companies, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001646972-26-000007, Size: 555 KB) disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement with no specific numerical financial metrics, transaction details, or other quantitative data provided in the filing summary. Sector not specified.
07-01-2026
Anterix Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001304492-26-000002, Size: 142 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or terms are disclosed in the provided summary. Sector is not specified.
07-01-2026
FUELCELL ENERGY INC filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001597, Size: 282 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector not specified.
07-01-2026
Terra Innovatum Global N.V. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002159, Size: 215 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No details on the specific officer, position affected, appointment/resignation status, reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Inotiv, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001160) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on delisting reasons, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.
07-01-2026
DT Cloud Star Acquisition Corp filed an 8-K on January 7, 2026 (AccNo: 0001493152-26-000803, Size: 265 KB) under Item 8.01 Other Events announcing a Merger/Acquisition. No specific deal structure, parties involved, valuation, consideration, synergies, regulatory details, or financial metrics are disclosed. Sector not specified.
07-01-2026
Angi Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001705110-26-000005, size 148 KB) under Item 2.05 disclosing costs associated with exit or disposal activities. No specific details on the nature of activities, dollar amounts, or financial impacts are provided. Sector not specified.
07-01-2026
Constellation Brands, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0000016918-26-000002, Size: 20 MB) disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US market, sector not specified. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary.
07-01-2026
CIMG Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000802, Size: 225 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits are provided. Sector not specified.
07-01-2026
U S PHYSICAL THERAPY INC /NV filed a Form 8-K on January 07, 2026 (AccNo: 0000885978-26-000003, Size: 722 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data, named entities beyond the filer, and material impacts are NOT_DISCLOSED.
07-01-2026
ClearSign Technologies Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001752, Size: 219 KB) disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source. No specific financial metrics, transaction values, or other quantitative details are mentioned in the provided information.
07-01-2026
Mobileye Global Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001757, Size: 188 KB) under Item 2.02 reporting Results of Operations and Financial Condition. Sector is not specified. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001761), disclosing Item 3.02 Unregistered Sales of Equity Securities and Item 7.01 Regulation FD Disclosure. No details on the unregistered sales, transaction values, share counts, or content of the Regulation FD disclosure are provided. This is a multi-item general filing with size 20 KB.
07-01-2026
GridAI Technologies Corp. filed an 8-K on 2026-01-07 (AccNo: 0001104659-26-001755, Size: 313 KB) under Item 2.01 announcing the Completion of Acquisition or Disposition of Assets. Item 9.01 discloses Financial Statements and Exhibits. No details on parties involved, deal structure, valuation, or strategic rationale are provided.
07-01-2026
CHEETAH NET SUPPLY CHAIN SERVICE INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001754, Size: 209 KB), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No specific details on the accountant change, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary. This is a general filing from the US SEC with sector not specified.
07-01-2026
Public Storage filed a Form 8-K on January 7, 2026 (AccNo: 0001628280-26-001156, Size: 357 KB) reporting Item 7.01 Regulation FD Disclosure and Item 8.01 Other Events. No details on core events, transactions, financial metrics, or named entities are explicitly stated in the provided filing summary. All quantitative data such as transaction values, share counts, and percentages are NOT_DISCLOSED.
07-01-2026
Saratoga Investment Corp. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002156, Size: 537 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific numerical data, transaction details, or further context provided in the filing summary. Sector is not specified.
07-01-2026
Exxon Mobil Corp filed a Form 8-K on January 07, 2026, under Item 7.01 Regulation FD Disclosure. Accession Number: 0000034088-26-000030. File size: 255 KB. No specific details on the disclosure content, events, transactions, or financial impacts are provided.
07-01-2026
AMERICAN COASTAL INSURANCE Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001401521-26-000003, Size: 145 KB), reporting solely under Item 8.01 Other Events. No details on the specific event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a single-item, voluntary disclosure with sector not specified.
07-01-2026
Anywhere Real Estate Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006274, Size: 176 KB), reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific details on vote outcomes, disclosures, transactions, or financial metrics provided. Sector not specified.
07-01-2026
COGENT COMMUNICATIONS HOLDINGS, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001748, Size: 265 KB) disclosing an officer change under Item 5.02. Item 5.02 covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits; no specific details on individuals, positions, reasons, or compensation provided.
07-01-2026
Kura Sushi USA, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006345, Size: 609 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or detailed results are disclosed in the provided filing summary. This is a financial results announcement from the US market.
07-01-2026
BCB Bancorp Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006261, Size: 132 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006341, Size: 169 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, exhibits, transaction values, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with sector not specified.
07-01-2026
Phathom Pharmaceuticals, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006266, size: 164 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.
07-01-2026
Healthcare Realty Trust Inc filed a Form 8-K on 2026-01-07 (AccNo: 0001360604-26-000009, Size: 338 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer's name, title, reason for change, or other quantitative data are provided. Event dated January 07, 2026; sector not specified.
07-01-2026
Jefferies Financial Group Inc. filed an 8-K on January 07, 2026 (AccNo: 0000096223-26-000003, Size: 676 KB) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or transaction details provided in the filing summary. Sector is not specified.
07-01-2026
Turn Therapeutics Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001213900-26-002173, Size: 38 MB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 07, 2026. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided summary.
07-01-2026
Photronics Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001140361-26-000510, size: 1 MB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, appointment or resignation status, reasons, or quantitative data are provided.
07-01-2026
Franklin Covey Co filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006335), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific quantitative data, transaction details, or performance metrics provided in the filing summary. Sector is not specified.
07-01-2026
bioAffinity Technologies, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000814, Size: 290 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
07-01-2026
Legacy Education Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000815, size 35 MB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financials, or named entities are disclosed in the provided filing summary. Sector not specified.
07-01-2026
BION ENVIRONMENTAL TECHNOLOGIES INC filed a Form 8-K on January 07, 2026 (AccNo: 0001079973-26-000047, Size: 182 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided information. Sector is not specified.
07-01-2026
Medalist Diversified REIT, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001772, size 153 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals involved, reasons, or financial terms are provided.
07-01-2026
OMEGA HEALTHCARE INVESTORS INC filed a Form 8-K on 2026-01-07 (AccNo: 0001104659-26-001774, Size: 193 KB) reporting an officer change under Item 5.02. Item 5.02 addresses Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No details on specific officers, positions affected, appointment or resignation status, reasons, or quantitative financial data are disclosed.
07-01-2026
Copper Property CTL Pass Through Trust filed a Form 8-K on January 07, 2026 (AccNo: 0001837671-26-000002, size 668 KB), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector not specified.
07-01-2026
NEXGEL, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000813, Size: 257 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided.
07-01-2026
Venus Concept Inc. filed an 8-K on January 7, 2026 (AccNo: 0001140361-26-000509, Size: 288 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties, financial impacts, or other specifics are disclosed in the provided summary. Sector not specified.
07-01-2026
Aeries Technology, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001829126-26-000086, size 257 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement, transaction value, or other specifics are provided.
07-01-2026
Ecovyst Inc. filed an 8-K on January 7, 2026 (AccNo: 0001708035-26-000010, Size: 369 KB) announcing completion of an acquisition or disposition of assets (Item 2.01), triggering events that accelerate or increase direct financial obligations or off-balance sheet arrangements (Item 2.04), and departure/election of directors or officers with compensatory arrangements (Item 5.02), including financial statements and exhibits (Item 9.01). No specific details on transaction parties, structure, value, or financial metrics are disclosed. Sector not specified.
07-01-2026
AZZ INC filed a Form 8-K on January 07, 2026 (AccNo: 0000008947-26-000012, Size: 592 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, revenue, earnings, or quantitative data are disclosed in the provided filing information. Sector is not specified.
07-01-2026
Evergy, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006331, Size: 670 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for material corporate events involving agreements and financial obligations. No specific transaction details, dollar values, parties, or quantitative impacts are disclosed in the provided filing summary.
07-01-2026
Black Stone Minerals, L.P. filed a Form 8-K on January 7, 2026 (AccNo: 0001621434-26-000005, Size: 166 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's position, name, appointment/departure status, reasons, or quantitative data are disclosed in the provided filing summary.
07-01-2026
FibroGen Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006327, Size: 334 KB), reporting under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the nature of amendments, events, transaction values, or exhibits are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
PriceSmart Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001041803-26-000008), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the filing summary. This is a standard financial results disclosure without detailed content provided.
07-01-2026
agilon health, inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001168, Size: 147 KB) disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected officers, appointment/resignation type, reasons, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006322, Size: 467 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is classified as a General Filing from us_sec with no sector specified. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing information.
07-01-2026
Immuneering Corp filed a Form 8-K on January 7, 2026, under Item 8.01 Other Events. Accession number 0001790340-26-000006, file size 153 KB. No details on the specific event, transaction, or financial impacts are disclosed.
07-01-2026
Quantumzyme Corp. filed a Form 8-K on January 7, 2026 (AccNo: 0001477932-26-000072, Size: 130 KB), reporting Item 5.03 regarding amendments to Articles of Incorporation or Bylaws or a change in fiscal year. No specific details on the nature of the amendments, transaction values, or other numerical data are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
APPYEA, INC filed an 8-K on January 07, 2026 (AccNo: 0001493152-26-000819, Size: 5 MB) announcing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), departure/election/appointment of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), with financial statements and exhibits (Item 9.01). No specific parties, deal structure, valuation, or financial terms are disclosed.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0000899689-26-000003, size 244 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). This is classified as a Material Event. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided filing summary.
07-01-2026
Matthews International Corp filed a Form 8-K on January 7, 2026 (AccNo: 0000063296-26-000004, Size: 176 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the financial statements/exhibits are provided. Sector not specified.
07-01-2026
CERO THERAPEUTICS HOLDINGS, INC. filed an 8-K on January 07, 2026 (AccNo: 0001213900-26-002187, Size: 12 MB), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Sector not specified. No specific details on events, transactions, financials, or numerical values provided in the filing summary.
07-01-2026
M-tron Industries, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000790, Size: 691 KB), reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing as a material event. No specific transaction details, dollar values, parties, or financial metrics are disclosed.
07-01-2026
Constellation Energy Corp filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001780, size 13 MB) reporting a Merger/Acquisition event, including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Changes in Directors/Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
AZZ INC filed a Form 8-K on January 07, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Accession Number: 0000008947-26-000014; File Size: 178 KB. No specific details on the event, transaction, or exhibits are disclosed in the provided filing summary.
07-01-2026
The company filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006347, Size: 326 KB) reporting Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item general filing with no specific details on transactions, dollar values, share counts, or other quantitative data provided in the filing summary. All financial metrics, named entities, and core event descriptions are NOT_DISCLOSED.
07-01-2026
Crinetics Pharmaceuticals, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006421, Size: 477 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific events, transactions, financial impacts, or exhibits are provided in the filing summary. All transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
07-01-2026
The company filed an 8-K on January 7, 2026 (AccNo: 0001914496-26-000002, Size: 171 KB), reporting Item 3.02 (Unregistered Sales of Equity Securities) and Item 7.01 (Regulation FD Disclosure). This is a multi-item general filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed. Event type is General Filing from us_sec source, sector not specified.
07-01-2026
Innovative Eyewear Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001829126-26-000089, Size: 265 KB) disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results announcement with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.
07-01-2026
Jefferies Financial Group Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001140361-26-000518, Size: 2 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary.
07-01-2026
Interactive Strength, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006397, Size: 289 KB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), and 9.01 (Financial Statements and Exhibits). No specific details on transaction values, parties involved, dollar amounts, share counts, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no timing details on business hours compliance available.
07-01-2026
Kaiser Aluminum Corp disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006395, Size: 268 KB), under Item 5.02 covering departures or elections of directors/officers and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer's identity, position, appointment/resignation status, or reasons are provided.
07-01-2026
Jasper Therapeutics, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002185, Size: 289 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Sector is not specified.
07-01-2026
Globus Medical Inc filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001189, Size: 161 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results with no specific numerical data, transaction values, or performance metrics provided in the summary. It is a multi-item filing focused on earnings-related information.
07-01-2026
Installed Building Products, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001188, Size: 213 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing under Regulation FD for material non-public information disclosure, with exhibits attached. No specific details on the core event, financial impacts, or quantitative data are disclosed in the provided filing summary.
07-01-2026
Ventas, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001785, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure of a material event. No specific transaction details, dollar values, or other quantitative data are disclosed in the provided filing summary.
07-01-2026
NON INVASIVE MONITORING SYSTEMS INC /FL/ filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000822, size: 446 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 financial statements and exhibits. No specific details on the agreement, obligation, transaction value, parties, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Commerce.com, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006391, Size: 170 KB) disclosing results of operations and financial condition (Item 2.02), costs associated with exit or disposal activities (Item 2.05), departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). Specific details on officer changes, financial metrics, or reasons are NOT_DISCLOSED. Event type is Officer Change from US SEC source.
07-01-2026
Greystone Housing Impact Investors LP filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006382, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or other quantitative data are disclosed in the provided filing summary.
07-01-2026
GD Culture Group Ltd filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002180, Size: 217 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing shareholder vote matters and attaching exhibits, with no specific vote details, outcomes, or financial data provided in the summary. Sector not specified.
07-01-2026
MSP Recovery, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006375, Size: 270 KB), reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided information.
07-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000821, Size: 225 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.
07-01-2026
Biofrontera Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000823, Size: 267 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This is a single-item mandatory disclosure likely filed promptly upon receipt of notice. No details on delisting reasons, financial impacts, transaction values, or sector are disclosed.
07-01-2026
Company filed an 8-K on January 7, 2026 (AccNo: 0001298675-26-000003, Size: 7 MB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a financial results event from the US SEC. No specific financial metrics, transaction values, or quantitative data disclosed in the provided filing summary.
07-01-2026
This is a Form 8-K filing under Item 8.01 Other Events dated January 07, 2026, with Accession Number 0001193125-26-006466 and file size 131 KB. Event type is listed as General Filing from us_sec source. No specific details on the core event, transaction, financials, or entities are disclosed in the provided filing information; sector not specified.
07-01-2026
Charles & Colvard Ltd disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001104659-26-001804, Size: 181 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or quantitative data are provided in the available information. Sector is not specified.
07-01-2026
Warner Bros. Discovery, Inc. filed an 8-K on January 07, 2026, reporting under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on individuals, transactions, or numerical values disclosed in the provided summary. All quantitative data and named entities beyond the filer are NOT_DISCLOSED.
07-01-2026
SharonAI Holdings, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001829126-26-000090, size: 197 KB), reporting changes in its certifying accountant under Item 4.01 and including financial statements and exhibits under Item 9.01. No details on the former or new accountant, reasons for the change, financial impacts, or other specifics are disclosed in the provided filing summary. Sector not specified.
07-01-2026
Zevia PBC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000800, Size: 183 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector not specified.
07-01-2026
Innovative Food Holdings Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001185185-26-000059, Size: 8 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, personnel changes, events, or exhibits are provided in the summary. Sector is not specified.
07-01-2026
TriUnity Business Services Ltd filed an 8-K on 2026-01-07 (AccNo: 0001477932-26-000074, Size: 6 MB) disclosing a merger/acquisition event under Items 1.01 (Entry into Material Definitive Agreement), 2.01 (Completion of Acquisition/Disposition of Assets), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Changes in Directors/Officers), 5.03 (Amendments to Articles/Bylaws), and 9.01 (Financial Statements/Exhibits). Specific details on deal structure, parties involved, valuation, consideration type, synergies, regulatory pathway, shareholder impacts, or quantitative metrics such as transaction value, share counts, or percentages are NOT_DISCLOSED. Analysis limited to filing items triggered, indicating a completed material M&A with governance and equity changes.
07-01-2026
ALTA Equipment Group Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006446, Size: 479 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are provided.
07-01-2026
Form 8-K filed on January 07, 2026 (AccNo: 0001104659-26-001809, Size: 196 KB) reports under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transaction details, companies, people, numerical values, or other events are explicitly described. Event type is General Filing from US SEC source; sector not specified.
07-01-2026
Toll Brothers, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0000794170-26-000006, Size: 761 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are provided. Sector is not specified.
07-01-2026
Resideo Technologies, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006506, Size: 139 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the summary. Sector is not specified.
07-01-2026
Applied Digital Corp. filed a Form 8-K on January 7, 2026 (AccNo: 0001144879-26-000002, Size: 587 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This discloses financial results. No specific revenue, earnings, transaction values, or other metrics are mentioned.
07-01-2026
Richardson Electronics, Ltd. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006497, Size: 931 KB), reporting results of operations and financial condition under Item 2.02 and including financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Topgolf Callaway Brands Corp. filed an 8-K on January 7, 2026 (AccNo: 0000837465-26-000003, size 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, or financial metrics were mentioned. Sector not specified.
07-01-2026
Windtree Therapeutics Inc./DE/ filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000805, Size: 145 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment/resignation status, reasons, or any numerical data are provided in the filing summary. Sector is not specified.
07-01-2026
Fat Brands, Inc. disclosed an officer change via Form 8-K filed on 2026-01-07 (AccNo: 0001493152-26-000827, Size: 321 KB) under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. Sector is not specified.
07-01-2026
Cartica Acquisition Corp filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001822, Size: 320 KB), reporting the termination of a material definitive agreement under Item 1.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, parties, valuation, or rationale are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
SurgePays, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000830, Size: 291 KB) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or quantitative terms such as compensation amounts are disclosed.
07-01-2026
Resources Connection, Inc. filed an 8-K on January 7, 2026 (AccNo: 0001084765-26-000004, Size: 591 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific numerical financial metrics, transaction values, or other quantitative details provided in the filing summary. Sector is not specified.
07-01-2026
VisionWave Holdings, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001731122-26-000023, size 313 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or compensation are provided.
07-01-2026
Green Dot Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001386278-26-000002, Size: 137 KB) under Item 7.01 for Regulation FD Disclosure. This is a voluntary disclosure of material non-public information as required by Regulation FD. No specific details on events, transactions, financial metrics, or other content are provided in the filing summary.
07-01-2026
Super League Enterprise, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001437749-26-000808, Size: 556 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transactions, values, names, or financial impacts disclosed in the provided summary. Sector not specified.
07-01-2026
Ventyx Biosciences, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006520, Size: 936 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing for material events, but specific details of the agreement, disclosures, or exhibits are NOT_DISCLOSED in the provided summary. No transaction values, financial impacts, or named counterparties are mentioned.
07-01-2026
Oncology Institute, Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001079973-26-000051, Size: 251 KB), triggering Items 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data provided in the filing summary. Sector not specified.
07-01-2026
Amerant Bancorp Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001734342-26-000004, Size: 6 MB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's nature, parties, value, or financial impacts are disclosed in the provided summary.
07-01-2026
Company filed an 8-K on 2026-01-07 (AccNo: 0001193125-26-006514, Size: 1 MB) as a Material Event reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with event date January 07, 2026, from source us_sec; sector not specified. No details on the core event, transaction value, financial impacts, or named entities are disclosed.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0001552781-26-000004, Size: 188 KB) reporting under Item 1.01 entry into a Material Definitive Agreement. Event date is January 7, 2026, classified as a Material Event from us_sec source. No details on the agreement parties, terms, value, or strategic context are disclosed in the provided filing summary; sector not specified.
07-01-2026
Propanc Biopharma, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000834, Size: 207 KB) under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. Sector is not specified. No additional details on reasons, financial impacts, or transaction values are disclosed.
07-01-2026
Fresh Del Monte Produce Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001047340-26-000003, Size: 138 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any numerical data are provided in the available information. Sector is not specified.
07-01-2026
Sadot Group Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001731122-26-000022, Size: 258 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on individuals, reasons, compensation, or quantitative impacts are disclosed in the provided summary.
07-01-2026
Glimpse Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000835, Size: 227 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Sector not specified. No details on the specific events, transactions, or exhibits provided.
07-01-2026
EON Resources Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001213900-26-002201, Size: 240 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or quantitative data are disclosed in the provided information.
07-01-2026
LGL GROUP INC filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000821, Size: 196 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's position (e.g., CEO, CFO), appointment or resignation status, reasons, or any quantitative financial metrics are disclosed in the provided information. Sector is not specified.
07-01-2026
ECD Automotive Design, Inc. filed a Form 8-K on January 7, 2026, under Item 8.01 Other Events. Accession number: 0001437749-26-000819; file size: 175 KB. No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary.
07-01-2026
Karman Holdings Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006581, Size: 514 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.
07-01-2026
Senmiao Technology Ltd filed an 8-K on January 7, 2026 (AccNo: 0001213900-26-002216, Size: 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers departure/election of directors/officers and compensatory arrangements (Item 5.02) and includes financial statements/exhibits (Item 9.01). No specific details on parties, structure, valuation, or terms are disclosed.
07-01-2026
Montauk Renewables, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006546, Size: 207 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement's counterparties, terms, value, or exhibits provided in the available information. All transaction specifics, financial impacts, and strategic context are NOT_DISCLOSED.
07-01-2026
Great Elm Group, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006542, Size: 15 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transaction values, or strategic implications are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Omeros Corp filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000820, size 154 KB) under Item 2.02 disclosing Results of Operations and Financial Condition as part of financial results. No specific revenue, earnings, transaction values, guidance, or other financial metrics are mentioned. Sector is not specified.
07-01-2026
Imunon, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000841, Size: 212 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, or quantitative data are provided.
07-01-2026
KB Home filed a Form 8-K on January 7, 2026 (AccNo: 0000795266-26-000009, Size: 182 KB), disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, appointment/resignation status, reasons, names, or quantitative data are provided in the available information. Sector is not specified.
07-01-2026
BLUM HOLDINGS, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000818, Size: 273 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.
07-01-2026
Orchid Island Capital, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001437749-26-000817, size: 171 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item filing in the US equity market from an unspecified sector.
07-01-2026
Datavault AI Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001832, Size: 231 KB), reporting Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific event details, transaction values, or financial metrics disclosed in the provided information. Sector is not specified.
07-01-2026
Crown Equity Holdings, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001477932-26-000081, Size: 124 KB), reporting Item 4.01: Changes in Registrant's Certifying Accountant. No details on the former or new accountant, reasons for the change, financial impacts, or other quantitative data are disclosed in the provided filing information. This is a mandatory disclosure for such events.
07-01-2026
The company filed a Form 8-K on January 7, 2026 (AccNo: 0000950142-26-000079), disclosing Items 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the unregistered sales, other events, transaction values, share counts, financial impacts, or exhibits are provided in the filing metadata. All quantitative data and named entities are NOT_DISCLOSED.
07-01-2026
Arena Group Holdings, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000851, Size: 383 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, events, transaction values, counterparties, or financial metrics disclosed in the provided information. All quantitative and qualitative details beyond the items reported are NOT_DISCLOSED.
07-01-2026
Datavault AI Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001828, Size: 224 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the disclosures, events, transactions, or financial data are provided in the filing summary. Sector not specified.
07-01-2026
Texas Ventures Acquisition III Corp filed an 8-K on January 7, 2026 (AccNo: 0001104659-26-001830, Size: 386 KB) disclosing under Item 1.01 entry into a Material Definitive Agreement related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific parties, deal structure, valuation, or other details are disclosed in the provided filing summary.
07-01-2026
Onar Holding Corp filed an 8-K on January 7, 2026 (AccNo: 0001477932-26-000079) disclosing the completion of an acquisition or disposition of assets under Item 2.01, along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on transaction parties, structure, value, or rationale are provided in the filing summary. Sector is not specified.
07-01-2026
Praxis Precision Medicines, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001825, Size: 559 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the financial statements/exhibits are disclosed in the provided filing summary. Sector not specified.
07-01-2026
RANGE IMPACT, INC. filed an 8-K on 2026-01-07 (AccNo: 0001493152-26-000850, Size: 4 MB) announcing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, consideration, synergies, or regulatory aspects are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Vivakor, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001829126-26-000094, Size: 248 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, share counts, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values or percentages are NOT_DISCLOSED.
07-01-2026
Nixxy, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001683168-26-000143, size 834 KB), reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
07-01-2026
Tidal Commodities Trust I filed a Form 8-K on January 7, 2026 (AccNo: 0001999371-26-000395, Size: 194 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are stated. Sector is not specified.
07-01-2026
Jet.AI Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001493152-26-000847, Size: 556 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer position, appointment/resignation, reason, or compensation are disclosed.
Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 237 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC